Cellectar Biosciences Inc (CLRB) is near the top in its industry group according to InvestorsObserver. CLRB gets an overall rating of 80. That means it scores higher than 80 percent of stocks. Cellectar Biosciences Inc gets a 94 rank in the Biotechnology industry. Biotechnology is number 32 out of 148 industries.

Searching for the best stocks to invest in can be difficult. There are thousands of options and it can be confusing on what actually constitutes a great value. Investors Observer allows you to choose from eight unique metrics to view the top industries and the best performing stocks in that industry. A score of 80 would rank higher than 80 percent of all stocks.

These rankings allows you to easily compare stocks and view what the strengths and weaknesses are of a given company. This lets you find the stocks with the best short and long term growth prospects in a matter of seconds. The combined score incorporates technical and fundamental analysis in order to give a comprehensive overview of a stocks performance. Investors who then want to focus on analysts rankings or valuations are able to see the separate scores for each section.

Cellectar Biosciences Inc (CLRB) stock is down -2.73% while the S&P 500 has risen 0.7% as of 9:45 AM on Monday, Dec 28. CLRB is lower by -$0.06 from the previous closing price of $2.20 on volume of 160,048 shares. Over the past year the S&P 500 has risen 15.76% while CLRB is lower by -5.31%. CLRB lost -$1.19 per share the over the last 12 months.

Click Here to get the full Stock Score Report on Cellectar Biosciences Inc (CLRB) Stock.

See original here:
Is Cellectar Biosciences Inc (CLRB) the Top Pick in the Biotechnology Industry? - InvestorsObserver